Bio-Works Technologies AB Stock
Equities
BIOWKS
SE0007387089
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 SEK | -2.00% | -22.63% | -58.59% |
Sales 2021 | 56.36M 5.15M 7.04M | Sales 2022 | 41.32M 3.78M 5.16M | Capitalization | 736M 67.32M 92.04M |
---|---|---|---|---|---|
Net income 2021 | -12M -1.1M -1.5M | Net income 2022 | -45M -4.11M -5.62M | EV / Sales 2021 | 15.2 x |
Net cash position 2021 | 103M 9.39M 12.84M | Net cash position 2022 | 65.88M 6.02M 8.23M | EV / Sales 2022 | 16.2 x |
P/E ratio 2021 |
-66.3
x | P/E ratio 2022 |
-16.4
x | Employees | 36 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 56.22% |
1 day | -2.00% | ||
1 week | -22.63% | ||
Current month | -28.64% | ||
1 month | -28.81% | ||
3 months | -48.06% | ||
6 months | -57.51% | ||
Current year | -58.59% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Royce
CEO | Chief Executive Officer | 47 | 20-06-25 |
Founder | - | 05-12-31 | |
Arne Hauge
DFI | Director of Finance/CFO | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | 71 | 13-09-23 | |
Johan Sedihn
BRD | Director/Board Member | 59 | 20-05-14 |
Peter Nählstedt
BRD | Director/Board Member | 50 | 20-05-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.94 | -2.00% | 46,634 |
24-04-25 | 3 | +8.70% | 40,711 |
24-04-24 | 2.76 | -2.13% | 34,771 |
24-04-23 | 2.82 | -2.76% | 45,698 |
24-04-22 | 2.9 | -23.68% | 241,749 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:17 am
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.59% | 10.45M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- BIOWKS Stock